Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;3(4):215-8.
doi: 10.3978/j.issn.2227-684X.2014.10.01.

Biochemical prognostic indicators for pancreatic neuroendocrine tumors and small bowel neuroendocrine tumors

Christine S Landry  1 , Keith Cavaness  1 , Scott Celinski  1 , John Preskitt  1
Affiliations

Biochemical prognostic indicators for pancreatic neuroendocrine tumors and small bowel neuroendocrine tumors

Christine S Landry et al. Gland Surg. 2014 Nov.

Abstract

Pancreatic neuroendocrine tumors (PNETs) and small bowel neuroendocrine tumors (SBNETs) are rare tumors that are frequently diagnosed late in the course of the disease. Several biomarkers have been proposed in the literature as prognostic factors for patients with these tumors. This article discusses a recent publication in Annals of Surgical Oncology from the University of Iowa analyzing the effect of different biomarkers on survival in patients with PNETs and SBNETs.

Keywords: 5-hydroxyindoleacetic acid (5-HIAA); Pancreatic neuroendocrine tumors (PNETs); chromogranin A (CgA); neurokinin A; neuron specific enolase; pancreastatin; pancreatic polypeptide; serotonin; small bowel neuroendocrine tumors (SBNETs).

PubMed Disclaimer

References

    1. Ries LA, Young JL, Keel GE, et al. eds. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD, 2007.
    1. Sherman SK, Maxwell JE, O’Dorisio MS, et al. Pancreastatin predicts survival in neuroendocrine tumors. Ann Surg Oncol 2014;21:2971-80. - PMC - PubMed
    1. Diebold AE, Boudreaux JP, Wang YZ, et al. Neurokinin A levels predict survival in patients with stage IV well differentiated small bowel neuroendocrine neoplasms. Surgery 2012;152:1172-6. - PubMed
    1. Turner GB, Johnston BT, McCance DR, et al. Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours. Gut 2006;55:1586-91. - PMC - PubMed
    1. Carling RS, Degg TJ, Allen KR, et al. Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease. Ann Clin Biochem 2002;39:577-82. - PubMed